US Patent Issued to Alnylam Pharmaceuticals on July 28 for "Serpin family F member 2 (SERPINF2) iRNA compositions and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,494, issued on July 28, was assigned to Alnylam Pharmaceuticals Inc. (Cambridge, Mass.).

"Serpin family F member 2 (SERPINF2) iRNA compositions and methods of use thereof" was invented by Jingxuan Liu (West Roxbury, Mass.), James D. McIninch (Burlington, Mass.) and Patrick Haslett (Somerville, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to RNAi agents, e.g., double stranded RNA (dsRNA) agents, targeting the SERPINF2 gene. The invention also relates to methods of using such RNAi agents to inhibit expression of a SERPINF2 gene and to methods of preventing and treating a SERPINF2-associated disorder, e.g., a disor...